Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Danielle St. Germaine"'
Autor:
Christophe P. Stove, Donna M. Iula, Katleen Van Uytfanghe, Marthe M Vandeputte, Danielle St. Germaine, Nathan Layle
Publikováno v:
ACS CHEMICAL NEUROSCIENCE
Several 2-benzylbenzimidazole opioids (also referred to as "nitazenes") recently emerged on the illicit market. The most frequently encountered member, isotonitazene, has been identified in multiple fatalities since its appearance in 2019. Although r
Autor:
Donna M. Iula, Katleen Van Uytfanghe, Marthe M Vandeputte, Nathan Layle, Christophe P. Stove, Danielle St. Germaine
Several 2-benzylbenzimidazole opioids (also referred to as ‘nitazenes’) recently emerged on the illicit market. The most frequently encountered member, isotonitazene, has been identified in multiple fatalities since its appearance in 2019. Althou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::724fcc442d98e0f9bc8ea8dc7e5e95ac
https://doi.org/10.22541/au.160520665.59016513/v2
https://doi.org/10.22541/au.160520665.59016513/v2
Autor:
Nathan Layle, Donna M. Iula, Katleen Van Uytfanghe, Christophe P. Stove, Marthe M Vandeputte, Danielle St. Germaine
Several benzimidazole opioids (commonly known as nitazenes) have recently started to emerge on the illicit market. The most frequently encountered member, the highly potent isotonitazene, has been identified in multiple fatalities since its appearanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::447faef26e83eeedd255a4894713fff3
https://doi.org/10.22541/au.160520665.59016513/v1
https://doi.org/10.22541/au.160520665.59016513/v1
Autor:
Giuliano De Portu, John Slish, Matthew F. Ryan, Paul J. Dobrowolski, Danielle St. Germaine, Nicole M. Iovine, Joseph A. Tyndall, Judith Lucas, Lindsay A. L. Bazydlo, Emily Weeks, Martina Holder, Roy Gerona, Jordan Trecki, Marie-Carmelle Elie, Michael D. Schwartz, Michelle Plourde, James R. Hanley, Greg Endres, Kenneth H. Rand, Paul D. Myers
Publikováno v:
Clin Toxicol (Phila)
BACKGROUND: Synthetic cannabinoid containing products are a public health threat as reflected by a number of outbreaks of serious adverse health effects over the past 4 years. The designer drug epidemic is characterized by the rapid turnover of synth